These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11831540)

  • 1. Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers.
    Ferron GM; Paul J; Fruncillo R; Richards L; Knebel N; Getsy J; Troy S
    J Clin Pharmacol; 2002 Feb; 42(2):175-82. PubMed ID: 11831540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects.
    Ferron GM; Patat A; Parks V; Rolan P; Troy SM
    Br J Clin Pharmacol; 2003 Jul; 56(1):39-45. PubMed ID: 12848774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age and sex on the disposition of retigabine.
    Hermann R; Ferron GM; Erb K; Knebel N; Ruus P; Paul J; Richards L; Cnota HP; Troy S
    Clin Pharmacol Ther; 2003 Jan; 73(1):61-70. PubMed ID: 12545144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of retigabine/ezogabine.
    Tompson DJ; Crean CS
    Curr Clin Pharmacol; 2013 Nov; 8(4):319-31. PubMed ID: 23342983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects.
    Hermann R; Knebel NG; Niebch G; Richards L; Borlak J; Locher M
    Eur J Clin Pharmacol; 2003 Apr; 58(12):795-802. PubMed ID: 12698305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
    Tompson DJ; Crean CS; Reeve R; Berry NS
    Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of ethanol on the pharmacokinetics, pharmacodynamics, safety, and tolerability of ezogabine (retigabine).
    Crean CS; Tompson DJ
    Clin Ther; 2013 Jan; 35(1):87-93. PubMed ID: 23328270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
    Sachdeo R; Partiot A; Biton V; Rosenfeld WE; Nohria V; Tompson D; DeRossett S; Porter RJ
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending-Dose Studies in Healthy Subjects.
    Vernillet L; Greene SA; Kamin M
    Clin Pharmacol Drug Dev; 2020 May; 9(4):428-443. PubMed ID: 32087001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine.
    Hermann R; Borlak J; Munzel U; Niebch G; Fuhr U; Maus J; Erb K
    Pharmacogenomics J; 2006; 6(3):211-9. PubMed ID: 16402080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.
    Biton V; Gil-Nagel A; Brodie MJ; Derossett SE; Nohria V
    Epilepsy Res; 2013 Nov; 107(1-2):138-45. PubMed ID: 24094693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II.
    Borlak J; Gasparic A; Locher M; Schupke H; Hermann R
    Metabolism; 2006 Jun; 55(6):711-21. PubMed ID: 16713428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-retigabine: an N-propargyled retigabine with improved brain distribution and enhanced antiepileptic activity.
    Zhou P; Zhang Y; Xu H; Chen F; Chen X; Li X; Pi X; Wang L; Zhan L; Nan F; Gao Z
    Mol Pharmacol; 2015 Jan; 87(1):31-8. PubMed ID: 25319542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hemodialysis on pharmacokinetics of ezogabine/retigabine and its N-acetyl metabolite in patients with end stage renal disease.
    Tompson DJ; Buraglio M; Bullman J; Crean CS; Rayner K
    Curr Clin Pharmacol; 2014; 9(4):319-25. PubMed ID: 25387761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Combination of Lacosamide with Retigabine in Experimental Animals: An Isobolographic Analysis.
    Luszczki JJ; Zagaja M; Miziak B; Kondrat-Wrobel MW; Zaluska K; Wroblewska-Luczka P; Adamczuk P; Czuczwar SJ; Florek-Luszczki M
    Pharmacology; 2018; 101(1-2):22-28. PubMed ID: 28926841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of retigabine in adults with partial-onset seizures after long-term exposure: focus on unexpected ophthalmological and dermatological events.
    Brickel N; Hewett K; Rayner K; McDonald S; De'Ath J; Daniluk J; Joshi K; Boll MC; Tiamkao S; Vorobyeva O; Cooper J
    Epilepsy Behav; 2020 Jan; 102():106580. PubMed ID: 31731109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction potential of retigabine (ezogabine) with other antiepileptic drugs.
    Tompson DJ; Crean CS
    Curr Clin Pharmacol; 2014 May; 9(2):148-56. PubMed ID: 24219007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
    Brodie MJ; Lerche H; Gil-Nagel A; Elger C; Hall S; Shin P; Nohria V; Mansbach H;
    Neurology; 2010 Nov; 75(20):1817-24. PubMed ID: 20944074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.